Bleeding in anticoagulated patients ‘might flag cancer’
Emerging evidence suggests patients with AF who have a bleed should probably be investigated for malignancy, cardiologists warn.
Tag: Anticoagulant
Combination therapy ‘reduces risk of vascular events’ in PAD
A secondary trial analysis shows low-dose rivaroxaban and aspirin benefit high-risk patients with lower extremity PAD, authors say.
Anticoagulation halves mortality in severe COVID-19, study shows
A leading cardiologist says an RCTÂ is needed, but he is already anticoagulating hospitalised patients unless contraindicated.
Education strategy fails to increase anticoagulation in AF
Intervention to inform patients about reducing stroke risk falls short of what's needed, researchers say.
Parenteral anticoagulants associated with lower risk in COVID-19
Chinese study found a composite outcome was significantly better in those on the therapy.
Patients with severe COVID-19 may be at high vascular risk
New guidelines advise thromboprophylaxis.
Apixaban is safer than rivaroxaban in AF: study
Choosing between the two drugs is a choice between thrombotic or haemorrhagic risk.
Anticoagulants with antiplatelets ‘questionable’ in some with AF
Large registry study suggests higher risk of stroke and bleeding on dual therapy.
Post-thrombectomy intracranial bleed risk tied to type of anticoagulant
Patients on NOACs pre-stroke do not appear to be at increased risk, say researchers.
AF: Oral anticoagulants ‘severely underutilised’ in discharged patients
Large Australian study shows three in four patients with AF miss out on the therapy.
